Capravirine

DB08502InvestigationalSmall molecule

Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection.

Chemical structure of Capravirine
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection.Curator reviewed
Formula / weight
C20H20Cl2N4O2S · 451.369 g/mol (avg)
Code names
AG 1549 · AG 549 · S-1153

Resolves to

Compound
UNIIVHC779598XCAS178979-85-6ChEMBLCHEMBL435128PubChem1783
Structure
InChIKeyYQXCVAGCMNFUMQ-UHFFFAOYSA-NSMILESCC(C)C1=C(SC2=CC(Cl)=CC(Cl)=C2)N(CC2=CC=NC=C2)C(COC(N)=O)=N1
Targets
Q72547polP03366gag-polP04585gag-pol

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
225Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Capravirine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In